急性和慢性血管酶-1受体对抗作用逆转了动脉样硬化中的内皮功能障碍
A Prasad1, T Tupas-Habib, W H Schenke
1Cardiology Branch, Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Circulation
|May 24, 2000
概括
使用洛萨坦抑制 ангиотензин-1 (AT(1) 受体,通过增加氧化的可用性,改善了动脉样硬化患者的内皮功能障碍. 这表明AT(1) 受体阻塞可能为动脉样硬化提供治疗效益.
科学领域:
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
- 血管生物学 血管生物学
背景情况:
- 氨酸- ангиотензин系统通过促进内皮功能障碍在动脉动脉生成中发挥作用.
- 抗氨-1 (AT(1) 受体阻塞正在研究其改善内皮功能的潜力.
研究的目的:
- 为了确定AT(1) 受体抑制是否改善动脉样硬化患者的内皮功能障碍.
- 评估洛萨坦对微血管反应和血管扩张的影响.
主要方法:
- 在动脉样硬化患者和在动脉内洛萨坦药物注射前后的对照组中研究了对血管活性剂的微血管反应.
- 在口服洛萨坦治疗8周后,通过超声波评估了流媒体臂血管扩张.
- 测量了血清中氧化水平.
主要成果:
- 在患者中,静脉内洛萨坦抑制了血管收缩和增加了乙胆诱导的血管扩张.
- 口服洛萨坦治疗改善了流量介导的臂动脉扩张,并增加了血清氧化水平.
- 对反应性高血压的反应增强,而酸和酸甘油的反应保持不变.
结论:
- 在动脉样硬化患者中,AT(1) 受体抑制逆转了内皮功能障碍.
- 提高氧化的可用性是观察到的好处的一个关键机制.
- 动脉样硬化症的长期治疗潜力可能存在于AT(1) 受体阻塞中.
相关概念视频
Antihypertensive Drugs: Action of β1 Blockers
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Angiotensin II Receptor Blockers
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Antihypertensive Drugs: Vasodilators
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Vascular Spasm
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
Peripheral Artery Disease I: Introduction
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...


